MABLYTICS

Mablytics is a preclinical stage biotechnology company developing immunotherapies that are precisely delivered by means of a novel target... Innovation is our life-blood-it fuels our drive that ultimately helps physicians to treat with conviction, with clarity, and with care. Our deeper understanding of a cell-surface protein has elevated our ability to engineer better immunotherapies and provide hope for the future-paving the way to improve the lives of people diagnosed with difficult-to-treat cancers around the world.

Also known as: Mablytics, Inc.

Primary location: New York United States